Agency bosses' international drug safety coalition at "critical juncture", says US FDA's Hamburg
This article was originally published in SRA
Executive Summary
The international coalition of heads of medicines agencies that is being set up to provide strategic direction and leadership on how to ensure the integrity of the pharmaceutical supply chain in an increasingly globalized world is at a "critical juncture", according to Margaret Hamburg, the outgoing commissioner of the US Food and Drug Administration.